Literature DB >> 1856255

A sensitive high-performance liquid chromatographic analysis of propranolol in serum.

A A al-Angary1, Y M el-Sayed, M A al-Meshal, M M al-Dardiri, G M Mahrous.   

Abstract

A rapid and sensitive high-performance liquid chromatographic (HPLC) assay was developed for quantitative determination of propranolol in serum. The assay is performed after single extraction of propranolol and indenolol [internal standard (IS)] from alkalinized serum into ether and eluted from C-18 U Bondapak column with a mobile phase composed of methanol: 0.01 M phosphate buffer pH 3.4 (40:60%, v/v). The column eluant was monitored on a fluorescence detector. Measurement was achieved by taking the peak height ratio of propranolol and comparing it to that of the IS. The detection limit for propranolol in serum is 2.5 ng/ml. Intraday coefficients of variation (CV) ranged from 2.84 to 4.0% and interday (CVs) from 5.8 to 8.4% at three different concentrations. The relative and absolute recoveries varied from 93.8 to 102.3%. Preliminary stability tests showed that propranolol is stable for at least 3 weeks in serum after freezing. The method is applied for the determination of the pharmacokinetic parameters of propranolol after intravenous administration (1 mg/kg) to rabbits.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856255     DOI: 10.1111/j.1365-2710.1991.tb00289.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  2 in total

1.  Human intestinal permeability of piroxicam, propranolol, phenylalanine, and PEG 400 determined by jejunal perfusion.

Authors:  N Takamatsu; L S Welage; N M Idkaidek; D Y Liu; P I Lee; Y Hayashi; J K Rhie; H Lennernäs; J L Barnett; V P Shah; L Lesko; G L Amidon
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

2.  Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.

Authors:  Yu-Yuan Chiu; Kazutaka Higaki; Brien L Neudeck; Jeffrey L Barnett; Lynda S Welage; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.